In the News

Type:

Categories:

Search:

StarTribune: Counterpoint: Medtronic’s move will benefit all

Medtronic Deal Benefits All Its Stakeholders

Bloomberg: Medtronic to Buy Device Maker Covidien for $42.9 Billion

Seeking Alpha: Medtronic – Ultimate Success Of Covidien Acquisition Relies On Still Unknown Revenue Synergies

CNBC: Medtronic’s $43B Covidien deal�and Irish tax move

NY Times DealBook: Former Medtronic C.E.O. Defends Inversion Deal

A Perspective on Medtronic’s Acquisition of Covidien

HBS Working Knowledge: Fixing the “I Hate Work” Blues

Andrew Sorkin for NY Times: Do Drug Companies Make Drugs, or Money?

Landon Donovan’s Response to Coach Klinsmann

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121